![]()
|
Report Date : |
08.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
B G PARA PHARMACEUTICAL FACTORY LLC |
|
|
|
|
Formerly Known As : |
B G CAPSULES |
|
|
|
|
Registered Office : |
Industrial Area No. 2 Sheikh Zayed Road Jebel Ali Free Zone PO Box
31721 Dubai |
|
|
|
|
Country : |
United Arab Emirates |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
19.02.2001 |
|
|
|
|
Com. Reg. No.: |
56081, Dubai |
|
|
|
|
Legal Form : |
Limited Liability Company - LLC |
|
|
|
|
Line of Business : |
Production of medical and surgical requisites |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 250,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
UAE |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : B G PARA PHARMACEUTICAL FACTORY LLC
Also Known As : B G CAPSULES
Country of Origin : Dubai, United Arab Emirates
Legal Form : Limited Liability Company - LLC
Registration Date : 19th February 2001
Commercial Registration Number : 56081, Dubai
Trade Licence Number : 524428
Chamber Membership Number : 62370
Issued Capital : UAE Dh 300,000
Paid up Capital : UAE Dh 300,000
Total Workforce : 90
Activities : Production of medical and surgical requisites
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit
Limit : US$ 250,000
Person Interviewed : Ms Meline Rio Florido, Administrative Officer
B G PARA PHARMACEUTICAL FACTORY LLC
ALSO KNOWN AS: B G CAPSULES
Location : Industrial
Area No. 2
Street : Sheikh Zayed
Road
Area : Jebel Ali
Free Zone
PO Box : 31721
Town : Dubai
Country : United Arab
Emirates
Telephone : (971-4) 8801590
Facsimile : (971-4)
8801580
Mobile : (971-50)
7497521
Email : bgpharma@emirates.net.ae
Subject operates from a medium sized suite of offices and a factory that
are rented and located in the Jebel Ali Free Zone.
Name Nationality Position
· Wasifi Adeeb
Attaya American Managing Director
· Abdul Jalil Al
Balouki Emirati Director
· Izzat Safarini - General
Manager
· Jamal Al Farr - Production Manager
· Jamal Al Raizi - Sales
Manager
· Meline Rio Florido - Administrative
Officer
Date of
Establishment : 19th
February 2001
History : Subject was originally
established in 2001 between the following shareholders:
-
Wasifi Adeeb Attaya
-
Abdullah Al Hajiri
However in late 2007, Abdullah Al Hajiri
withdrew from the company after
assigning his share to Mr Abdul Jalil Al Balouki.
Legal Form : Limited Liability
Company - LLC
Commercial Reg.
No. : 56081, Dubai
Trade Licence No. : 524428
Chamber Member No. : 62370
Issued Capital : UAE Dh 300,000
Paid up Capital : UAE Dh 300,000
· Abdul Jalil Al Balouki 51%
· Wasifi Adeeb
Attaya 49%
· Sun Engineering
& Contracting LLC
Dubai
Activities: Engaged in the production of medical and surgical requisites,
specialising in empty hard gelatine capsules.
Subject’s plant was built, as a turnkey project by Technophar, a
Canadian company acknowledged as one of the leading companies in this field.
Production Capacity : 1 billion capsules per year.
Import Countries: Europe and the United States of America
Operating Trend: Steady
Subject has a workforce of 90 employees.
Financial highlights provided by local sources are given below:
Currency: United Arab Emirates Dirham (UAE Dh)
Year
Ending 31/12/09: Year
Ending 31/12/10:
Total Sales UAE
Dh 33,600,000 UAE Dh
35,750,000
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
·
National Bank of Dubai
Baniyas Street
PO Box:
777
Dubai
Tel: (971-4) 2222241
No complaints regarding subject’s payments have been reported.
Established in 2001, subject is involved in the production of medical
and surgical requisites, specialising in empty gelatine capsules that it
produces in quantities of 1 billion per year.
Please note that we were unable to contact the subject during our
investigation. As a result the report has been compiled from registered
information.
Local sources report that the subject’s operating history is clear with
payment obligations met in a generally timely manner. The financial position is
satisfactory and the company is deemed a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.42 |
|
|
1 |
Rs.70.95 |
|
Euro |
1 |
Rs.63.63 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.